Sector ratings GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:53 2026-07-16 EDT			5-day change	1st Jan Change
2,506.70 ^INR	+0.85%		+2.60%	+1.45%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	4.38B	-	-	-		-
ELI LILLY AND COMPANY	1,031B		A
JOHNSON & JOHNSON	595B		BBB
ABBVIE INC.	431B		AA	-
ROCHE HOLDING AG	326B		AA
NOVARTIS AG	277B		AAA
ASTRAZENECA PLC	263B		A
NOVO NORDISK A/S	224B		A
AMGEN INC.	193B		A
GILEAD SCIENCES, INC.	164B		AA
PFIZER INC.	141B		A
VERTEX PHARMACEUTICALS INCORPORATED	121B		AA
BRISTOL-MYERS SQUIBB COMPANY	120B		A
SANOFI	105B		AA
GSK PLC	103B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	72.37B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
BAYER AG	53.61B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	55.95B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	51.54B		AA
Average	219.79B		AA
Weighted average by Cap.			AA